Traditional factors currently used for prognostic stratification do not always adequately predict treatment response and disease evolution in advanced breast cancer patients. Therefore, the use of blood-based markers, such as circulating tumor cells (CTCs), represents a promising complementary strategy for disease monitoring. In this retrospective study, we explored the role of CTC counts as predictors of disease evolution in breast cancer patients with limited metastatic dissemination.
Circulating tumor cells as early predictors of metastatic spread in breast cancer patients with limited metastatic dissemination / Giuliano, Mario; Giordano, Antonio; Jackson, Summer; De Giorgi, Ugo; Mego, Michal; Cohen, Evan N; Gao, Hui; Anfossi, Simone; Handy, Beverly C; Ueno, Naoto T; Alvarez, Ricardo H; DE PLACIDO, Sabino; Valero, Vicente; Hortobagyi, Gabriel N; Reuben, James M; Cristofanilli, Massimo. - In: BREAST CANCER RESEARCH. - ISSN 1465-5411. - 16:5(2014), p. 440. [10.1186/s13058-014-0440-8]
Circulating tumor cells as early predictors of metastatic spread in breast cancer patients with limited metastatic dissemination
GIULIANO, MARIO;DE PLACIDO, SABINO;
2014
Abstract
Traditional factors currently used for prognostic stratification do not always adequately predict treatment response and disease evolution in advanced breast cancer patients. Therefore, the use of blood-based markers, such as circulating tumor cells (CTCs), represents a promising complementary strategy for disease monitoring. In this retrospective study, we explored the role of CTC counts as predictors of disease evolution in breast cancer patients with limited metastatic dissemination.| File | Dimensione | Formato | |
|---|---|---|---|
|
Giuliano et Al.BCR2015.pdf
accesso aperto
Tipologia:
Documento in Post-print
Licenza:
Dominio pubblico
Dimensione
964.97 kB
Formato
Adobe PDF
|
964.97 kB | Adobe PDF | Visualizza/Apri |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
